
Trump Administration Considers Covering Weight Loss Drugs for Medicare, Medicaid
The Trump administration is reportedly planning a significant five-year pilot program aimed at providing access to cutting-edge weight loss medications, including popular drugs like Ozempic, Wegovy, Mounjaro,…

Feds Launch Medicare Experiment to Cover GLP-1 Weight Loss Drugs
The federal government is embarking on a significant five-year experiment poised to reshape the landscape of obesity treatment by potentially expanding Medicare coverage for highly effective GLP-1…

Trump Administration Plans Experiment for Weight Loss Drug Coverage
A significant shift in U.S. healthcare policy is on the horizon as the Trump administration prepares a five-year experiment aimed at extending Medicare coverage and Medicaid expansion…